Nikolay Kislov

893 total citations
13 papers, 105 citations indexed

About

Nikolay Kislov is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Oncology. According to data from OpenAlex, Nikolay Kislov has authored 13 papers receiving a total of 105 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 8 papers in Physiology and 5 papers in Oncology. Recurrent topics in Nikolay Kislov's work include Erythrocyte Function and Pathophysiology (7 papers), Blood properties and coagulation (6 papers) and Erythropoietin and Anemia Treatment (4 papers). Nikolay Kislov is often cited by papers focused on Erythrocyte Function and Pathophysiology (7 papers), Blood properties and coagulation (6 papers) and Erythropoietin and Anemia Treatment (4 papers). Nikolay Kislov collaborates with scholars based in Russia, United States and United Kingdom. Nikolay Kislov's co-authors include A. V. Muravyov, И. А. Тихомирова, Sergey Cheporov, Bradley A. McGregor, Elaine T. Lam, Aly‐Khan A. Lalani, Paul B. Robbins, Stan Krulewicz, Alessandra di Pietro and Brian I. Rini and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Cancer Research and Annals of Oncology.

In The Last Decade

Nikolay Kislov

13 papers receiving 102 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nikolay Kislov Russia	7	54	48	26	17	14	13	105
Luca Campedel France	6	42 0.8×	32 0.7×	9 0.3×	17 1.0×	20 1.4×	26	93
Elisna Syahruddin Indonesia	9	81 1.5×	71 1.5×	13 0.5×	43 2.5×	67 4.8×	39	196
Danny Houtsma Netherlands	6	38 0.7×	42 0.9×	15 0.6×	22 1.3×	22 1.6×	19	98
Romain Geiss France	6	33 0.6×	54 1.1×	43 1.7×	50 2.9×	24 1.7×	19	151
Adrien Guérard France	3	44 0.8×	28 0.6×	15 0.6×	62 3.6×	40 2.9×	5	114
Jianhui Huang China	9	26 0.5×	55 1.1×	30 1.2×	28 1.6×	60 4.3×	19	155
G. Oliviéro France	7	98 1.8×	73 1.5×	19 0.7×	22 1.3×	18 1.3×	15	135
Fumimasa Kitamura Japan	8	25 0.5×	65 1.4×	14 0.5×	20 1.2×	51 3.6×	16	132
Mercè Barenys Spain	5	88 1.6×	54 1.1×	6 0.2×	43 2.5×	50 3.6×	11	170

Countries citing papers authored by Nikolay Kislov

Since Specialization

Citations

This map shows the geographic impact of Nikolay Kislov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nikolay Kislov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nikolay Kislov more than expected).

Fields of papers citing papers by Nikolay Kislov

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nikolay Kislov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nikolay Kislov. The network helps show where Nikolay Kislov may publish in the future.

Co-authorship network of co-authors of Nikolay Kislov

This figure shows the co-authorship network connecting the top 25 collaborators of Nikolay Kislov. A scholar is included among the top collaborators of Nikolay Kislov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nikolay Kislov. Nikolay Kislov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Pivot, Xavier, Javier Cortés, Diana Lüftner, et al.. (2023). Cardiac Safety and Efficacy of SB3 Trastuzumab Biosimilar for ERBB2-Positive Early Breast Cancer. JAMA Network Open. 6(4). e235822–e235822. 7 indexed citations

Ahn, Myung‐Ju, Igor Bondarenko, Ewa Kalinka‐Warzocha, et al.. (2023). Durvalumab in Combination With Olaparib Versus Durvalumab Alone as Maintenance Therapy in Metastatic NSCLC: The Phase 2 ORION Study. Journal of Thoracic Oncology. 18(11). 1594–1606. 8 indexed citations

Kislov, Nikolay, et al.. (2022). The impact of therapeutic enteral nutrition on quality of life in cancer patients in need of palliative care. P A Herzen Journal of Oncology. 11(2). 33–33. 3 indexed citations

Bilen, Mehmet Asım, Brian I. Rini, Martin H. Voss, et al.. (2021). Association of Neutrophil-to-Lymphocyte Ratio with Efficacy of First-Line Avelumab plus Axitinib vs. Sunitinib in Patients with Advanced Renal Cell Carcinoma Enrolled in the Phase 3 JAVELIN Renal 101 Trial. Clinical Cancer Research. 28(4). 738–747. 28 indexed citations

Felip, Enriqueta, Eric Vallières, C.Z. Zhou, et al.. (2021). LBA9 IMpower010: Sites of relapse and subsequent therapy from a phase III study of atezolizumab vs best supportive care after adjuvant chemotherapy in stage IB-IIIA NSCLC. Annals of Oncology. 32. S1319–S1319. 8 indexed citations

Kislov, Nikolay, et al.. (2020). Regional clinical and economic model of colorectal cancer screening. SHILAP Revista de lepidopterología. 7(3). 146–159. 6 indexed citations

Muravyov, A. V., et al.. (2019). Cellular models of erythrocytes for studying the effect of gasotransmitters on their microrheology. 5(1). 3–10. 4 indexed citations

Тихомирова, И. А., et al.. (2016). Alteration of red blood cell microrheology by anti-tumor chemotherapy drugs. Biochemistry (Moscow) Supplement Series A Membrane and Cell Biology. 10(2). 135–141. 3 indexed citations

Muravyov, A. V., et al.. (2016). Red blood cell microrheological effects of some antitumor chemotherapy drugs: In vitro study. 1(2). 151–158. 1 indexed citations

10.

Тихомирова, И. А., et al.. (2016). Interrelation of blood coagulation and hemorheology in cancer. Clinical Hemorheology and Microcirculation. 64(4). 635–644. 17 indexed citations

11.

Muravyov, A. V., et al.. (2011). Red blood cell aggregation changes are depended on its initial value: Effect of long-term drug treatment and short-term cell incubation with drug. Clinical Hemorheology and Microcirculation. 48(4). 231–240. 7 indexed citations

12.

Muravyov, A. V., et al.. (2010). Comparative efficiency and hemorheological consequences of hemotransfusion and epoetin therapy in anemic cancer patients. Clinical Hemorheology and Microcirculation. 44(2). 115–123. 6 indexed citations

13.

Muravyov, A. V., et al.. (2009). Hemorheological changes in solid tumor patients after treatment with recombinant erythropoetin. Clinical Hemorheology and Microcirculation. 41(1). 39–47. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact